GT Biopharma Inc GTBP

US Biotechnology

$6.89 ▲ +0.88% (+$0.06)

Open $6.79

Prev Close $6.83

Day Range $6.59 – $7.24

52W Range $4.91 – $34.25

Market Cap $12.43M

Beta 0.85

EPS (TTM) $-47.51

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2013-10-22
Shares Out.	44,340,000
Website	gtbiopharma.com/ ↗
Phone	13026587581
Employees	1
Revenue	$0
Gross Profit	$0
Net Income	-$4.5M
Free Cash Flow	-$14.4M
Total Assets	$5.8M
Total Liabilities	$2.2M
Equity	$3.6M

About GT Biopharma Inc

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

GT Biopharma Inc is a publicly traded company under the ticker symbol GTBP on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.